by rss feed | Nov 14, 2026 | Adam Feuerstein, AMT-130, Huntingtons Disease, Matt Kapusta, News Feeds, weekly reads
Last week I wrote about some seemingly encouraging news from uniQure, a firm pursuing a treatment for Huntington’s disease. The FDA had cleared the firm’s BLA. However, I should have given additional background as there’s a more complex backstory...